Literature DB >> 28496572

Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes?

Dhanunjaya R Lakkireddy1, George E Blake1, Dimpi Patel2, Martin Rotter3, Atul Verma4, Kay Ryschon5, Mohammed Khan3,6, Robert Schweikert6, Michel Haissaguerre7, Andrea Natale8,9,10.   

Abstract

Background: Catheter ablation of atrial fibrillation (AF) is an increasingly popular therapeutic option for symptomatic patients who have failed multiple antiarrhythmic drugs (AADs). Patients of higher body mass index often fail direct current cardioversion. The role of body mass index (BMI) on the success of AF ablation is not well understood.
Methods: We prospectively studied 511 patients who underwent AF ablation at the Cleveland Clinic Foundation between 2002 and 2005. Patients were divided into four classes based on their BMI: Class I ( 25); Class II (25.1-30); Class III (30.1-35) and Class IV (>35). These groups were compared for baseline demographic and clinical characteristics. Any recurrence of AF after 3 months of ablation was considered as failure. All classes were followed for at least 12 months and rates of failure were compared.
Results: Based on their BMI, 25% of patients were assigned to class I, 37% in class II, 21% in class III and 16% in class IV. Patients of higher classification (class III or IV) were more likely to be male (p<0.001), diabetic (p<0.001), smokers (p=0.002), with coronary artery disease (=0.018), left atrial enlargement (p=0.015) and longstanding AF (p=0.007). Severity of obesity as measured by BMI had a direct correlation to early (p=0.05) and late (p=0.01) recurrence of AF.
Conclusion: Obesity is significantly associated with long-term AF recurrence after catheter ablation. Higher incidence of smoking &amp; left atrial enlargement may possibly contribute to higher failure rates in this sub-group of patients.

Entities:  

Keywords:  Ablation; Arrhythmia; Atrial Fibrillation; Obesity; Risk Factors

Year:  2008        PMID: 28496572      PMCID: PMC5398797          DOI: 10.4022/jafib.36

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  52 in total

1.  Atrial fibrillation: the epidemic of the new millennium.

Authors:  M D Ezekowitz
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

2.  Atrial fibrillation, obesity, and obstructive sleep apnea.

Authors:  Miguel A Arias; Ana M Sánchez; Alberto Alonso-Fernández; Francisco García-Río
Journal:  Arch Intern Med       Date:  2007-07-23

3.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

4.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

5.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

6.  Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans.

Authors:  V K Somers; A L Mark; D C Zavala; F M Abboud
Journal:  J Appl Physiol (1985)       Date:  1989-11

Review 7.  Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure.

Authors:  Karen E Joynt; David J Whellan; Christopher M O'connor
Journal:  J Card Fail       Date:  2004-06       Impact factor: 5.712

8.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

9.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

10.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

View more
  2 in total

1.  Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.

Authors:  Milton Packer
Journal:  Cardiovasc Diabetol       Date:  2019-09-24       Impact factor: 9.951

2.  Proceedings From the 2019 Stanford Single Ventricle Scientific Summit: Advancing Science for Single Ventricle Patients: From Discovery to Clinical Applications.

Authors:  Sushma Reddy; Stephanie Siehr Handler; Sean Wu; Marlene Rabinovitch; Gail Wright
Journal:  J Am Heart Assoc       Date:  2020-03-19       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.